title: Critical evaluation of blood-saving measures for high-risk patients.
authors.affiliation: Department of Anesthesiology and General Intensive Care, University of Vienna, Austria.
authors.forename: T
authors.initials: T
authors.lastname: Hartmann
authors.forename: M
authors.initials: M
authors.lastname: Winkler
authors.forename: C
authors.initials: C
authors.lastname: Preis
authors.forename: P
authors.initials: P
authors.lastname: Germann
authors.forename: A
authors.initials: A
authors.lastname: Donner
authors.forename: C
authors.initials: C
authors.lastname: Müller
mesh_terms: D007611:Aprotinin / Q000627:therapeutic use; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001803:Blood Transfusion / Q000379:methods* / Q000592:standards; D001804:Blood Transfusion, Autologous; D000075202:Contraindications; D016638:Critical Illness; D004322:Drainage; D004921:Erythropoietin / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D006438:Hemodilution; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D007023:Hypotension, Controlled; D007430:Intraoperative Care; D007501:Iron / Q000627:therapeutic use; D010347:Patient Care Planning; D010956:Plasmapheresis; D011182:Postoperative Care; D011187:Posture; D011300:Preoperative Care; D011786:Quality Control; D012307:Risk Factors; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use
chemical_list: D006490:Hemostatics; D015842:Serine Proteinase Inhibitors; D004921:Erythropoietin; D007611:Aprotinin; D007501:Iron